1. Introduction
Chitin (CH; poly-β-(1,4)-
N-acetyl glucosamine) occurs in the exoskeletons of crustaceans, insects and the cell walls of algae and fungi. CH has a protective and supporting function; it is responsible for the rigidity of the exoskeletons of insects and crustacean, and its presence in the cell walls of fungi and algae facilitates movement [
1]. Currently, there are no synthetic methods for preparing CH. As a result, methods to obtain CH are dependent on extraction from crustaceans and algae. Usually, these methods are carried out in the following sequence: deproteinization, demineralization and discoloration [
2]. The methods of preparation, as well as physical and chemical characterization of CH, are the subject of an extensive review by Daraghmah et al. [
1].
Usually, CH exists in different organisms in its “complexed” forms with proteins, carbohydrates, or lipids. This means that CH, in order to interact with other chemical functional groups in the tissues of organisms, must have free functional binding groups. This is clear evidence that CH must have some deacetylated domains which means it cannot be isolated in pure form. Consequently, purification of CH involves freeing this insoluble material from various debris and other active matter such as deacetylated derivatives; namely, chitosan (CHS) and glucosamine. It seems that there is no clear demarcation between extraction and purification of CH which is therefore obtained with different molecular weights ranging from hundreds to thousands of kDa. Regardless of variations in molecular weight, CH can occur in three distinct existing polymorphic forms: α, β and γ. CH polymer chains in the α polymorph are aligned in an anti-parallel fashion, whilst in β polymorphs the alignment occurs in parallel. In the γ form the CH polymer chains are arranged in a pattern whereby two parallel chains are in one direction whilst the third is in the opposite direction [
1]. Whether or not the anatomical variation of CH in a particular organism affects the mechanical properties of extracted CH is still the subject of active research.
CH is a polymer which is insoluble in water and other conventional solvents. It has a structure deprived of active functional groups. This leaves the CH surface without any reactive functional groups with no ability to react with any chemical moieties; thus, it is chemically inert. In addition, its lack of absorption in the human body allows it to be considered as a pharmacologically inert material. This means it is an ideal material to be used as a pharmaceutical excipient from both a chemical and pharmacological perspective [
3,
4]. Furthermore, CH is classified as grass in the FDA classification for materials safety usage [
5]. This unique characteristic keeps the door open for future use as a pharmaceutical excipient particularly in liquid and solid dosage forms. The challenge in utilizing CH in solid pharmaceutical preparations is its powder flow and mechanical characteristics, including compaction and compression [
6].
It may be advantageous to highlight the similarity of CH with the most popular excipient in pharmaceutical solid dosage form preparations, i.e., cellulose and its derivatives such as micro crystalline cellulose (MCC) [
7]. MCC shares with CH its β-(1,4) glycosidic bond, and its relative chemical and pharmacological inertness. Researchers in the CH field are attempting to emulate and test if the same techniques which have been successfully used to modify MCC can be applied in the field of CH research, particularly in solid pharmaceutical dosage form preparations [
8,
9].
It is well known that, like MCC, CH and CHS powder flow properties suffer from low bulk density. This causes unsmooth flow which is attributed to the fibrous nature of these natural polymers [
6,
10]. Attempts to alleviate this drawback have been tested by adding silicon dioxide to CH and CHS powders [
11,
12]. The addition of silicon dioxide facilitates smooth flow in tableting machines. Furthermore, combining CH/CHS with Avicel PH201, starch 1500, calcium carbonate or gelatin have been tested and were found to dramatically improve the flow behavior of the composite powders [
13,
14,
15]. The improvement in flow properties has encouraged novel applications of these composites in producing pharmaceutical solid dosage forms excipients, especially as direct compression excipients. It is worth mentioning that various attempts to utilize CH as a novel solid drug delivery system were carried out by Daraghmeh et.al. [
16], whereby CH was co-processed with mannitol to produce orodispersible tablets able to disintegrate in the mouth within a few seconds. Furthermore, CH was formulated, by Gana et.al. [
17], with cephalosporins and metal silicates in order to obtain an insight into the effect of pH on the CH surface and its influence on drug stability. Abu Fara et al. [
8] used roller compaction to improve CH powder flow qualities and to make its compression and compaction characteristics compatible for use in industrial pharmaceutical machines. Additionally, there are some on-going trials to extend the use of CH and CHS as excipients in a similar method followed in improving MCC powder flow using spray drying [
6,
18]. Such studies, show that CH is a suitable solid pharmaceutical excipient. As a result, it can be concluded that CH powder modification is essential in order to commercialize this novel excipient.
Natural polymers usually contain crystalline and amorphous domains in their structure. The balance between these two components controls the powder flow behavior. It has been reported that during the compaction of MCC, its crystalline domains are responsible for fragmentation while its amorphous domains are responsible for polymer plasticity, which induces bonding [
7]. This is confirmed in the case of lactose, whereby amorphous lactose offers better compactibility than the crystalline form [
19,
20]. Accordingly, it seems that an amorphous powder is more compactable but the bulk density is usually lower than the crystalline material. Consequently, studying the impact of the crystalline-amorphous balance on powder flow is a pre-requisite to its industrial use. However, a review of the scientific literature does not show if CH polymorphs differ in their response towards compression and compaction.
CH has diverse functions in different tissues in an organism; e.g., the CH in the lining of the gastrointestinal tract in some organisms is more flexible to suite its functional role and has more elasticity than exoskeleton CH, which is a harder material. Such functionality raises the question whether CH polymorphs behave in a similar manner when compressed, or does the functional use dictate their mechanical strength, as expressed in different tissues of organism? As sea food remains from industrial packaging contain a mixture of CH with various origins, it would be interesting to compare extracted CH from the most utilized CH sources, namely shrimp, crab and squid. These organisms are known to have α (shrimp and crab) and β (squid) CH polymorphs. Such polymorphs can be differentiated by their powder X-ray diffraction patterns. It would be interesting to test each polymorph individually and discern the differences in their compaction and compression behavior.
The present work focuses on pharmaceutical powder compression and compaction properties of CH extracted from the most widely used sea food organisms namely crabs, shrimps, and squids. The influence of variation in α and β CH polymorphic forms due to CH extraction source on compression and compaction is explored. Hence it may be possible to ascertain whether CH sources must be processed separately or collectively prior to their extraction.
3. Discussion
The prime objective of the present investigation was to test CHs extracted from different sources to assess their similarity and suitability for use as a future excipient in pharmaceutical solid dosage form preparations. The final goal is to reach a conclusion whether remains from the sea food packaging industry need to be classified according to their source prior to CH extraction process. This concern becomes evident when one screens the different scientific literature on CH, where there are indications that CH from different sources are chemically similar, but their mechanical properties vary [
25].
The strategy followed in this work was to compare CH from crabs and shrimps, both of which belong to α polymorph, in order to find out if the variation in CH source has any influence on the extracted polymer compression and compaction properties. Furthermore, a comparison between α and β-CH polymorphs extracted from squid pins, regarding their compression and compaction behavior, was also conducted. Mixtures of the two polymorphs were also prepared, and their physical and mechanical properties were studied. Whether or not these polymorphic forms could facilitate compaction of two model drugs, namely metronidazole and spiramycin, which are difficult to compress on their own, was tested.
It is well known that shrimps, crabs and squids are the most used organisms in the sea food packaging industry [
26]. These organisms differ in their species and their extracted CH is confined to the three well characterized and known polymorphs; α, β and γ. It is essential to first confirm this primary information. The Fourier-transform infrared (FT-IR) spectra of CH-Cr, CH-Sh, and CH-Sq are shown in
Figure 1. Distinct vibrational bands appear at a wavelength of 1620–1660 with a distinct split in the band for α-chitin (
Figure 1a,b), while there is a single sharp band for β-CH (
Figure 1c). This confirms different previous reports on CH of α and β polymorphs [
23,
27]. Further confirmation of the polymorphic type was carried out using X-ray powder diffraction,
Figure 2. The γ polymorph is scarce due to its limited occurrence in the lining of the digestive system of different organisms such as squid. Consequently, the present investigation was limited to a comparison of the compression and compaction behavior of the most commercially available two polymorphs, α and β. Such a comparison helps to clarify if the source of CH extraction causes variation in their related mechanical properties when compacted.
In addition to identifying polymorphic forms of molecules, XRPD has been used as a tool to shed light on the crystallinity and arrangement of CH in different polymer fibers.
Figure 2 confirms α polymorph in CH-Cr and CH-Sh, and β polymorph in CH-Sq. The crystalline index,
Table 5, shows that the α polymorph is more crystalline than the β polymorph; 84–85% in CH-Cr and CH-Sh, and 73% in CH-Sq. SEM images,
Figure 3,
Figure 4,
Figure 5 and
Figure 6 show the parallel arrangements of β-CH sheets with clear spacing. This is indicative of their ability to hydrate and gel much more than α polymorph [
23,
27]. Interestingly, the β polymorph shows a smaller pore size and pore volume which may indicate that the value of the parameter a (the capillary water effect) may contribute to its functional strength and flexibility in squid pins. Indeed, the water content determination of CH-Sq shows almost double the value of Ch-Cr and CH-Sh (
Table 3). This dramatic variation in water content is an important difference which can be beneficial in the use of CH as excipients for pharmaceutical solid dosage forms. Water content results are consistent with the fact that β-CH (CH-Sq) is more susceptible to intra-crystalline hydration than α-CH (CH-Cr and CH-Sh) due to its lack of intra-sheet hydrogen bonds [
23].
Bulk densities of the three types of CH (
Table 2) are different although shrimp and crab are similar in polymorphic form. The difference between shrimp and crab CH measured bulk densities may be due to a difference in material arrangements in nature in those living organisms depending on their functional use. Such variation has been previously reported, where extracted CHs from male and female grasshoppers show some differences in CH content and surface morphology [
27]. Accordingly, one would expect to observe some variations in CH extracted even from the same species. The higher crab and shrimp chitin bulk densities indicate that these powder samples comprise denser aggregated particles. Such aggregation could be a result of particle-particle adherence which may be attributed to the highly fibrous structure of CH-Cr and CH-Sh, whereas CH-Sq displays a structure which is much less fibrous (
Figure 5 and
Figure 6). The plain surface of CH-Sq with no fibrous extensions is responsible for the absence of an interlocking structural network, which consequently leads to the formation of aggregated particles in CH-Cr and CH-Sh.
As expected, all types of CH did not provide good flowability as indicated by their HR and CI values (
Table 2), which is attributed to their low bulk densities. The foregoing has led, various workers, to suggestion that these powders be treated by roller compaction or slugging before using them as excipients [
8]. Thus CH-Sh would be more favorable for tablet compression than CH-Cr and CH-Sq since it has the lowest HR and CI values.
Parameters from Heckle and Kawakita equations indicate that shrimp powder is more resistance to compression than the other two sources. This is reflected in the force required for compression (
PK) which is significantly higher in value than for the other two CH samples (
Table 6). Such variation makes the work required for compression higher, as emphasized in the data in
Figure 10. Indeed, this is a real indication that differences in CH properties, such as bulk and tapped densities, are reflected in the compression forces required to convert the powders into compacts. The mechanical properties of CH are similar to cellulose derivatives e.g., micro crystalline cellulose (MCC), where reports have shown that various cellulose polymorphs behave differently in response to compaction forces. MCC requires a disintegration agent when used in tablet manufacturing whilst CH powders are self-disintegrating. This is advantageous in terms of the use of CH for pharmaceutical dosage forms which need to be dissolved in the buccal cavity.
The three parameters extracted from the Kawakita equation, namely
a,
ab, and
PK, are interesting. CH from different sources, which show differences in particle morphology and crystallography, has concurrently shown differences in powder compression behavior. Among the three types, CH-Sq (β-CH) displays the highest volume reduction (
a), particle rearrangement (
ab), and the lowest compression force (
PK) to reduce the powder bed volume (
Table 6). In other words, in order to produce a compact, CH-Sq requires the smallest force to yield the highest volume reduction in comparison with CH-Cr and CH-Sh (α-CHs). This may be attributed to the anti-parallel and parallel arrangement of α- and β-polymorphs, respectively. As a matter of fact, CH-Cr and CH-Sh responses to compression vary although they belong to the same polymorph. This may be due to variation in the mechanical strength of the extracted materials. Concurrently, examining the results from Heckel analysis (
Table 7) CH-Sq is the highest plastically deforming material, it can be stated that compression of the less fibrous and less aggregated material, i.e., CH-Sq, is more mechanically engaged in the deformation of the highly plastic material than the more fibrous one, i.e., CH-Cr and CH-Sh. Such a high extent of deformation shown by CH-Sq contributes to the high reduction of its powder bed volume upon compression compared to CH-Cr and CH-Sh. Moreover, the high extent of deformation of CH-Sq enables the appearance of fresh new surfaces for surface-to-surface contact and bridging [
28,
29]. Thus, compacts made of CH-Sq have a higher crushing strength than compacts made of CH-Cr and CH-Sh (
Table 8).
Although the α-polymorph is more resistant to reduction in size compared to the β-polymorph, such behavior does not hinder both polymorphs from possessing an excellent crushing strength and very short disintegration time. This means direct compression of these individual powders can be utilized in preparing tablets or films which can dissolve in the mouth within seconds liberating the active content. This property can be highly advantageous and utilized in oral dissolving tablets, which are required to dissolve fast but at the same time be composed of a hard compact. The extracted CH polymorphs fit very well for such a function and future research potentially bodes well in this direction. However, due to its fast dissolving characteristics, CH can be used as a disintegrating agent; indeed, this has been previously reported [
1,
11]. Both polymorphs can be used as direct compression excipients in pharmaceutical formulations, either as whole or partially, and their need for a driving force for compaction is low, allowing ease of use in tableting machines.
Bearing in mind that the work/energy of compression is the product of force and displacement, CH-Sq manifested the lowest energy needed for compression (
Figure 10), since it manifested the lowest compression force (or lowest
PK) needed to produce the hardest compacts (
Table 6 and
Table 8). Irrespective of the fact that hard compacts can be made using CH-Sq, a disintegration time of less than one minute, like other CH sources, makes the super-disintegration power of CH independent of tablet hardness.
The dissolution performance of formulations containing CH from different sources was studied and compared with Rodogyl
® formulation, which contains a superdisintegrant and a filler with disintegrant action [
29] in addition to two drugs: spiramycin and metronidazole. The drug release profile for the two drugs formulated with CH-Cr, CH-Sh, and CH-Sq and the mixture CH-Sh5Sq5 showed that 8.3% CH was sufficient to attain faster and complete drug release compared to Rodogyl
®, for both spiramycin and metronidazole (
Figure 12 and
Figure 13). However, the release of the two drugs in formulations containing CH-Sq was slightly slower than that in formulations containing CH-Cr and CH-Sh. Nevertheless, the mixture containing CH-Sh5Sq5 speeded up the drug release from CH-Sq formulations for both drugs. This makes it necessary to use more than one source of CH in the drug formulations. Thus, a combination of CH sources is recommended to attain optimized tablet physical properties and optimum drug release profile.
Mixtures of CH polymorphs demonstrate an optimized action when compacted. This results in a satisfactory mixture suitable to be compressed and compacted. At first glance, this may suggest to gather remains from sea food packaging industry without classification, but such process shall yield CH with different characteristics depending on the percentage of squid remains involved in extraction process. Such operational procedure will result in lack of consistency in the extracted CH in each produced batch, which would in turn influence the manufactured dosage forms. Consequently, separating the organisms before CH extraction would yield a homogeneous CH powder, enabling pharmaceutical formulator to take advantage when formulating dosage forms by adding the required polymorph in the formulation stage depending on required properties. Alpha polymorph CH is reasonably less expensive than beta polymorph which reserve this polymorph for certain required formulation functions. Indeed, this polymorph can be used to form tablets or films with excellent hardness capable of withstanding mechanical vibrations encountered throughout manufacturing, packaging and transferring steps. The main advantage of CH as an excipient is its ability to form hard compacts with a very short disintegration time. This gives this excipient an advantage compared to excipients based on cellulose derivatives, without any need to add a disintegrating agent to formulations containing CH. Thus, CH is a suitable future excipient. Differences in sources or polymorphic form extend its usage particularly as a solid dosage form excipient suitable for drugs required to be released in a very-short time. CH must be extracted using a single species process, whereby the extracted CH has a well-defined function.
As a general remark, these raw excipients must be exposed to a process of compaction; for example, by using roller compaction, as has been previously reported by our group [
8]. The variation in compaction properties between different sources of CH and their mixtures suggest that separation of sources yielding different polymorphs has an advantage in producing excipients with functional properties e.g., as a disintegrant or as filler. CH is chemically and pharmacologically inert and can be considered as a future pharmaceutical excipient.